Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025
Abbott Laboratories is in advanced talks to acquire cancer diagnostics specialist Exact Sciences, in what could be the healthcare giant’s largest deal in nearly a decade and a major shake-up for the global cancer testing market. Bloomberg+1 Abbott in Talks for Biggest Deal in Nearly a Decade On Wednesday, November 19, 2025, multiple outlets reported that Abbott Laboratories is close to a deal to buy Exact Sciences Corp., a U.S.-based molecular diagnostics company best known for its Cologuard colorectal cancer screening test. Bloomberg+1 According to people familiar with the matter cited by Bloomberg, Abbott is negotiating the terms of a